Related Experiment Video
Updated: Feb 8, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
The Impact of Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinoma: A Single Center Experience
Insights
Transarterial chemoembolization (TACE) is a safe and effective palliative treatment for hepatocellular carcinoma (HCC) patients in Barcelona Clinic Liver Cancer (BCLC) stage C. This study evaluated survival and complications in HCC patients receiving TACE.
Area of Science:
- Hepatology
- Oncology
- Interventional Radiology
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide.
- Barcelona Clinic Liver Cancer (BCLC) staging system is crucial for guiding treatment decisions.
- Transarterial chemoembolization (TACE) is a common palliative treatment for intermediate-stage HCC.
Purpose of the Study:
- To evaluate the survival outcomes and complications of hepatocellular carcinoma (HCC) patients.
- To assess the efficacy and safety of transarterial chemoembolization (TACE) in BCLC stage C HCC patients.
- To analyze data from Rajavithi Hospital, Thailand, between 2008 and 2012.
Main Methods:
- A descriptive retrospective study design was employed.
- Data were collected from patient medical records.
- Survival analysis was performed using the Kaplan-Meier method.
Main Results:
- The study included 44 patients with BCLC stage C HCC who received TACE.
- Median survival time was 7.1 months.
- Post-embolization syndrome (88.6%) was the most common complication, while liver failure (18.2%) was a major procedural-related complication.
Conclusions:
- Transarterial chemoembolization (TACE) demonstrated effectiveness and safety as a palliative treatment for HCC patients with BCLC stage C.
- The findings support the use of TACE in managing advanced HCC.
- Further research can explore optimizing TACE protocols for improved patient outcomes.
Objective:
The present study aimed to study survival and complications of hepatocellular carcinoma (HCC) patients with Barcelona Clinic Liver Cancer (BCLC) stage C who received transarterial chemoembolization (TACE) at Rajavithi Hospital, Thailand.
Material And Method:
The method used was a descriptive retrospective study using data collected from patient medical records from 2008 to 2012. The general information, complications, and causes of death of the patients were presented with descriptive statistics. Survival was analyzed using the Kaplan-Meier method.
Results:
During the 5-year period, our institution performed TACE on 396 patients. While 57 cases were classified as BCLC stage C, only 44 cases had complete records. The mean age of the patients was 56.3 years with an age range from 30 to 75 years. Thirty-six cases or 81.8% were male. Twenty-six cases or 59.1% had hepatitis B infections. Thirty-five cases or 79.5% were Child-Pugh A. The median survival time was 7.1 months. The most common complication was post-embolization syndrome which occurred in 39 patients (88.6%). Liver failure was a major procedural-related complication which occurred in 8 patients (18.2%) and was responsible for three deaths (6.8%).
Conclusion:
TACE in HCC patients with BCLC stage C at Rajavithi Hospital was an effective and safe palliative treatment.
More Related Videos
Related Concept Videos
Lattice Centering and Coordination Number
Types of Unit Cells
Imagine taking a large number of identical...
Center of Gravity
Center of Gravity
To determine its location, the principle of moments can be utilized by dividing the object into...
Impact of Groups on Groups
Center of Mass
The knowledge of the center of mass can also help us to describe and predict the motion of objects. For example, when a ball is thrown...
What is an Experiment?

